Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease

Dopamine plays a key role in a range of action control processes. Here, we investigate how dopamine depletion caused by Parkinson disease (PD) and how dopamine restoring medication modulate the expression and suppression of unintended action impulses. Fifty-five PD patients and 56 healthy controls (HCs) performed an action control task (Simon task). PD patients completed the task twice, once withdrawn from dopamine medications and once while taking their medications. PD patients experienced similar susceptibility to making fast errors in conflict trials as HCs, but PD patients were less proficient compared with HCs at suppressing incorrect responses. Administration of dopaminergic medications had no effect on impulsive error rates but significantly improved the proficiency of inhibitory control in PD patients. We found no evidence that dopamine precursors and agonists affected action control in PD differently. Additionally, there was no clear evidence that individual differences in baseline action control (off dopamine medications) differentially responded to dopamine medications (i.e., no evidence for an inverted U-shaped performance curve). Together, these results indicate that dopamine depletion and restoration therapies directly modulate the reactive inhibitory control processes engaged to suppress interference from the spontaneously activated response impulses but exert no effect on an individual's susceptibility to act on impulses.

[1]  H. Berendse,et al.  Failure of stop and go in de novo Parkinson's disease—a functional magnetic resonance imaging study , 2015, Neurobiology of Aging.

[2]  E. Wagenmakers,et al.  A Default Bayesian Hypothesis Test for ANOVA Designs , 2012 .

[3]  Marjan Jahanshahi,et al.  Effects of deep brain stimulation of the subthalamic nucleus on inhibitory and executive control over prepotent responses in Parkinson's disease , 2013, Front. Syst. Neurosci..

[4]  M. D’Esposito,et al.  Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation , 2005, Cognitive, affective & behavioral neuroscience.

[5]  E. Wagenmakers A practical solution to the pervasive problems ofp values , 2007, Psychonomic bulletin & review.

[6]  T. Cummins,et al.  Dopamine transporter genotype predicts behavioural and neural measures of response inhibition , 2012, Molecular Psychiatry.

[7]  Yu-Kang Tu,et al.  Revisiting the relation between change and initial value: a review and evaluation , 2007, Statistics in medicine.

[8]  B. Forstmann,et al.  Neurocognitive mechanisms of action control: resisting the call of the Sirens. , 2011, Wiley interdisciplinary reviews. Cognitive science.

[9]  K. R. Ridderinkhof,et al.  Inefficient response inhibition in individuals with mild cognitive impairment , 2007, Neuropsychologia.

[10]  N. V. Wouwe,et al.  Speed pressure in conflict situations impedes inhibitory action control in Parkinson's disease , 2014, Biological Psychology.

[11]  J. Bolam,et al.  Convergence of cortical and thalamic input to direct and indirect pathway medium spiny neurons in the striatum , 2013, Brain Structure and Function.

[12]  E. Soetens,et al.  Freezing of gait in Parkinson's disease: disturbances in automaticity and control , 2013, Front. Hum. Neurosci..

[13]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[14]  T. Videen,et al.  Mapping Go-No-Go performance within the subthalamic nucleus region. , 2010, Brain : a journal of neurology.

[15]  E. Cuny,et al.  Brain dopaminergic modulation associated with executive function in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[16]  J. Wijnen,et al.  Response inhibition in motor and oculomotor conflict tasks: Different mechanisms, different dynamics? , 2007, Brain and Cognition.

[17]  Thomas V. Wiecki,et al.  Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold , 2011, Nature Neuroscience.

[18]  Daniel N. Bub,et al.  Cognitive Control in Children , 2006, Psychological science.

[19]  R. Geenen,et al.  A simple test of the Law of Initial Values. , 1993, Psychophysiology.

[20]  Howard Poizner,et al.  Dopaminergic therapy in Parkinson's disease decreases cortical beta band coherence in the resting state and increases cortical beta band power during executive control , 2013, NeuroImage: Clinical.

[21]  K Richard Ridderinkhof,et al.  Delta plots in the study of individual differences: new tools reveal response inhibition deficits in AD/Hd that are eliminated by methylphenidate treatment. , 2005, Journal of abnormal psychology.

[22]  C. Adler,et al.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. , 2013, Brain : a journal of neurology.

[23]  C. Caltagirone,et al.  Dopamine Treatment and Cognitive Functioning in Individuals with Parkinson's Disease: The “Cognitive Flexibility” Hypothesis Seems to Work , 2014, Behavioural neurology.

[24]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[25]  K. Richard Ridderinkhof,et al.  The Effect of Parkinson's Disease on the Dynamics of On-line and Proactive Cognitive Control during Action Selection , 2010, Journal of Cognitive Neuroscience.

[26]  T. Robbins,et al.  Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication , 2000, Neuropsychologia.

[27]  K. R. Ridderinkhof,et al.  The effect of speed-accuracy strategy on response interference control in Parkinson's disease , 2009, Neuropsychologia.

[28]  J. R. Simon,et al.  Reactions toward the source of stimulation. , 1969, Journal of experimental psychology.

[29]  T. Price,et al.  Correcting for Regression to the Mean in Behavior and Ecology , 2005, The American Naturalist.

[30]  P. Moberg,et al.  Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.

[31]  S. Rossell,et al.  Genetic variations in dopamine and inhibitory control: Lack of influence on action restraint , 2014, Behavioural Brain Research.

[32]  K. R. Ridderinkhof,et al.  The effect of Parkinson's disease on interference control during action selection , 2009, Neuropsychologia.

[33]  C. Eriksen,et al.  Effects of noise letters upon the identification of a target letter in a nonsearch task , 1974 .

[34]  Pekka T. Männistö,et al.  Catechol-O-Methyltransferase , 1996, Encyclopedia of Molecular Pharmacology.

[35]  Graham V. Williams,et al.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory , 2007, Nature Neuroscience.

[36]  A. Dagher,et al.  Dopamine precursors depletion impairs impulse control in healthy volunteers , 2014, Psychopharmacology.

[37]  B. Hommel,et al.  Dopamine and inhibitory action control: evidence from spontaneous eye blink rates , 2009, Experimental Brain Research.

[38]  M. D’Esposito,et al.  Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.

[39]  Andrew T. Morgan,et al.  Behavioral/systems/cognitive Striatal Dopamine D 2 /d 3 Receptors Mediate Response Inhibition and Related Activity in Frontostriatal Neural Circuitry in Humans Impulsive Behavior Is Thought to Reflect a Traitlike Characteristic That Can Have Broad Consequences for an Individual's Success and Well-be , 2022 .

[40]  K. Lesch,et al.  Influence of SLC6A3 and COMT variation on neural activation during response inhibition , 2009, Biological Psychology.

[41]  Sean D. Kristjansson,et al.  Neural correlates of inhibitory control and functional genetic variation in the dopamine D4 receptor gene , 2014, Neuropsychologia.

[42]  Borís Burle,et al.  Executive control in the Simon effect: an electromyographic and distributional analysis , 2002, Psychological research.

[43]  T. Robbins,et al.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.

[44]  James D. Miles,et al.  Reaction time distribution analysis of spatial correspondence effects , 2011, Psychonomic bulletin & review.

[45]  K. R. Ridderinkhof,et al.  Version unknown SOURCE ( OR PART OF THE FOLLOWING SOURCE ) : Type article Title To head or to heed ? Beyond the surface of selective action inhibition : a review , 2022 .

[46]  M. Luquin,et al.  Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway , 2014, Neurobiology of Disease.

[47]  C. Marsden,et al.  'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.

[48]  A. Arnsten,et al.  Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. , 1997, The Journal of pharmacology and experimental therapeutics.

[49]  M. Myrtek,et al.  The law of initial value: A rare exception , 1986, Biological Psychology.

[50]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[51]  R. Duncan Luce,et al.  Response Times: Their Role in Inferring Elementary Mental Organization , 1986 .

[52]  T. Robbins,et al.  Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease , 2007, The Journal of Neuroscience.

[53]  K. Richard Ridderinkhof,et al.  Dopamine Agonists and the Suppression of Impulsive Motor Actions in Parkinson Disease , 2012, Journal of Cognitive Neuroscience.

[54]  P. Calabresi,et al.  Direct and indirect pathways of basal ganglia: a critical reappraisal , 2014, Nature Neuroscience.

[55]  Karmen K. Yoder,et al.  Cortical dopamine release during a behavioral response inhibition task , 2014, Synapse.

[56]  Jennifer Wiley,et al.  What Are the Odds? A Practical Guide to Computing and Reporting Bayes Factors , 2014, J. Probl. Solving.

[57]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[58]  Richard Ridderinkhof Micro- and macro-adjustments of task set: activation and suppression in conflict tasks , 2002, Psychological research.

[59]  M. Hallett,et al.  Freezing of gait: moving forward on a mysterious clinical phenomenon , 2011, The Lancet Neurology.

[60]  A. Osman,et al.  Dimensional overlap: cognitive basis for stimulus-response compatibility--a model and taxonomy. , 1990, Psychological review.

[61]  Jeffrey N. Rouder,et al.  Default Bayes factors for ANOVA designs , 2012 .

[62]  P. Lewitt,et al.  Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics , 2015, Movement disorders : official journal of the Movement Disorder Society.